TMCnet - World's Largest Communications and Technology Community



Personalis, Inc. Receives Accreditation from College of American Pathologists (CAP)
[April 23, 2014]

Personalis, Inc. Receives Accreditation from College of American Pathologists (CAP)

MENLO PARK, Calif. --(Business Wire)--

Personalis, Inc., a leading provider of genome-based diagnostics, announced today that its onsite clinical laboratory has received accreditation from the College of American Pathologists (CAP), meeting the highest standard of excellence in clinical laboratory practices. With this accreditation, Personalis, Inc. joins an elite group of globally recognized facilities that operate at the highest level of quality laboratory standards.

The CAP Laboratory Accreditation Program is a globally recognized program that utilizes teams of highly specialized laboratory professionals as inspectors. During the accreditation process, inspectors meticulously examine the clinical laboratory's records and quality control procedures. They also assess the laboratory's staff qualifications, equipment, facilities, safety program, and overall management to ensure it meets CAP's diverse and stringent requirements. The goal of the CAP program is to improve patient safety by advancing the quality of pathology and laboratory services through education and strict standards.

"We strive to provide quality service in every aspect of what we deliver to our customers," said John West, Personalis' CEO. "We feel that holding ourselves to the highest standards of laboratory practice is an integral part of our operations. With sevices such as our ACE Clinical Exome™, we are trying to find answers to the most difficult clinical cases. We are committed to providing the most accurate and thorough results possible to our customers, so they can provide the best possible care for their patients."

About the College of American Pathologists

The College of American Pathologists (CAP), celebrating 50 years as the gold standard in laboratory accreditation, is a medical society that serves more than 18,000 physician members and the global laboratory community. It is the world's largest association composed exclusively of board-certified pathologists and is the worldwide leader in laboratory quality assurance. The College advocates accountable, high-quality, and cost-effective patient care.

More information about the CAP can be found at

About Personalis, Inc.

Personalis, Inc. provides researchers and clinicians accurate DNA sequencing and interpretation of human exomes and genomes. We support researchers engaging in case-control, family-based, or proband-only genomic studies of disease, pharmacogenomics, and cancer. Our ACE (Accuracy and Content Enhanced) Technology supplements a standard exome or genome, substantially increasing its medically-relevant coverage and accuracy. Personalis builds on this enhanced sequencing foundation with innovative algorithms and proprietary databases for alignment, variant calling, annotation, and analysis. Through this comprehensive approach, we provide genomic data and interpretation of the highest accuracy. Personalis' ACE Clinical Exome™ has several major features that are not addressed by standard exome sequencing platforms: a high level of gene finishing, structural variant detection, and inclusion of non-exonic interpretable content. The ACE Clinical Exome™ has been specifically designed to enhance diagnostic yield for clinical care.

For more information about Personalis, Inc., please visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy